Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy.

Autor: Palomar-Abril V; Department of Medical Oncology, Hospital Universitario Doctor Peset, Comunitat Valenciana, 46017, Valencia, Spain. vicente.palomar.abril@gmail.com., Soria-Comes T; Department of Medical Oncology, Hospital Universitario Doctor Peset, Comunitat Valenciana, 46017, Valencia, Spain., Campos ST; Department of Applied Statistics, Operations Research and Quality, Universitat Politècnica de València, Comunitat Valenciana, Valencia, Spain., Ureste MM; Department of Medical Oncology, Hospital Universitario Doctor Peset, Comunitat Valenciana, 46017, Valencia, Spain., Bosch VG; Centre for Quality and Change Management, Universitat Politècnica de València, Comunitat Valenciana, Valencia, Spain., Maiques ICM; Department of Medical Oncology, Hospital Universitario Doctor Peset, Comunitat Valenciana, 46017, Valencia, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Dec; Vol. 22 (12), pp. 2333-2340. Date of Electronic Publication: 2020 May 24.

Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients.

Autor: Sesé M; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain., Somoza R; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Maestu I; Department of Medical Oncology, Hospital Universitario Doctor Peset, Valencia, Spain., Ureste MM; Department of Medical Oncology, Hospital Universitario Doctor Peset, Valencia, Spain., Sanchez A; Department of Medical Oncology, Consorci Hospitalari Provincial de Castelló, Castellón, Spain., Cordoba JF; Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Sansano I; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Venturas G; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Ramón Y Cajal S; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain., Hernández-Losa J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain. jahernan@vhebron.net.; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. jahernan@vhebron.net.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain. jahernan@vhebron.net.

Publikováno v: Oncology and therapy [Oncol Ther] 2019 Dec; Vol. 7 (2), pp. 131-139. Date of Electronic Publication: 2019 Aug 19.